These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9711374)

  • 1. Obsessive-compulsive disorder in post-streptococcal infection.
    Monasterio E; Mulder RT; Marshall TD
    Aust N Z J Psychiatry; 1998 Aug; 32(4):579-81. PubMed ID: 9711374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood.
    Perlmutter SJ; Leitman SF; Garvey MA; Hamburger S; Feldman E; Leonard HL; Swedo SE
    Lancet; 1999 Oct; 354(9185):1153-8. PubMed ID: 10513708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcal infections of skin and PANDAS.
    Carelli R; Pallanti S
    Dermatol Ther; 2014; 27(1):28-30. PubMed ID: 24502308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of psychogenic excoriation and obsessive compulsive disorder using aripiprazole and fluoxetine.
    Curtis AR; Richards RW
    Ann Clin Psychiatry; 2007; 19(3):199-200. PubMed ID: 17729023
    [No Abstract]   [Full Text] [Related]  

  • 5. Fluoxetine treatment of obsessive-compulsive disorder.
    Turner SM; Jacob RG; Beidel DC; Himmelhoch J
    J Clin Psychopharmacol; 1985 Aug; 5(4):207-12. PubMed ID: 3894437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset obsessive-compulsive disorder: the role of stressful life events.
    Velayudhan L; Katz AW
    Int Psychogeriatr; 2006 Jun; 18(2):341-4. PubMed ID: 16420720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A preliminary randomized double-blind clinical trial on the efficacy of celecoxib as an adjunct in the treatment of obsessive-compulsive disorder.
    Sayyah M; Boostani H; Pakseresht S; Malayeri A
    Psychiatry Res; 2011 Oct; 189(3):403-6. PubMed ID: 21329988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Silybum marianum (L.) Gaertn. with fluoxetine in the treatment of Obsessive-Compulsive Disorder.
    Sayyah M; Boostani H; Pakseresht S; Malayeri A
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):362-5. PubMed ID: 20035818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in the identification and treatment of PANDAS: a case series.
    Mabrouk AA; Eapen V
    J Trop Pediatr; 2009 Feb; 55(1):46-8. PubMed ID: 18499734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staying Up at Night: Overlapping Bipolar and Obsessive-Compulsive Disorder Symptoms in an Adolescent with Autism Spectrum Disorder.
    Cawkwell P; Lawler A; Maneta E; Coffey BJ
    J Child Adolesc Psychopharmacol; 2016 Feb; 26(1):74-7. PubMed ID: 26881860
    [No Abstract]   [Full Text] [Related]  

  • 11. Cognitive versus behavior therapy: processes of change in the treatment of obsessive-compulsive disorder.
    Anholt GE; Kempe P; de Haan E; van Oppen P; Cath DC; Smit JH; van Balkom AJ
    Psychother Psychosom; 2008; 77(1):38-42. PubMed ID: 18087206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients with obsessive-compulsive disorder (OCD) displayed cognitive deficits consistent with a dysfunction of the dorsolateral-striatal circuit.
    Fontenelle LF; Mendlowicz MV; Versiani M
    Psychol Med; 2004 Jan; 34(1):181; author reply 181-3. PubMed ID: 14971639
    [No Abstract]   [Full Text] [Related]  

  • 13. Ritanserin as adjunct to fluoxetine treatment of OCD patients with psychotic features.
    Bach M; Aigner M; Lenz G
    Pharmacopsychiatry; 1997 Jan; 30(1):28-9. PubMed ID: 9065968
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature].
    Etain B; Bonnet-Perrin E
    Encephale; 2001; 27(3):280-9. PubMed ID: 11488259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late occurrence of isolated obsessive-compulsive behavior in a boy with Wilson's Disease on treatment.
    Sahu JK; Singhi P; Malhotra S
    J Child Neurol; 2013 Feb; 28(2):277. PubMed ID: 23143727
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder.
    Neziroglu F; Yaryura-Tobias JA; Walz J; McKay D
    J Child Adolesc Psychopharmacol; 2000; 10(4):295-306. PubMed ID: 11191690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Manic behaviors associated with fluoxetine in three 12- to 18-year-olds with obsessive-compulsive disorder.
    Go FS; Malley EE; Birmaher B; Rosenberg DR
    J Child Adolesc Psychopharmacol; 1998; 8(1):73-80. PubMed ID: 9639082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obsessive-compulsive disorder: Part II. Treating the symptoms and studying the brain.
    Harv Ment Health Lett; 2005 Nov; 22(5):1-4. PubMed ID: 16408338
    [No Abstract]   [Full Text] [Related]  

  • 19. Is obsessive-compulsive disorder an autoimmune disease?
    Arnold PD; Richter MA
    CMAJ; 2001 Nov; 165(10):1353-8. PubMed ID: 11760984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic response to plasmapheresis in four cases with obsessive-compulsive disorder and tic disorder triggered by streptococcal infections].
    Beşiroğlu L; Ağargün MY; Ozbebit O; Sözen M; Dilek I; Güleç M
    Turk Psikiyatri Derg; 2007; 18(3):270-6. PubMed ID: 17853982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.